Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

@article{Leucht2012AntipsychoticDV,
  title={Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis},
  author={S. Leucht and M. Tardy and K. Komossa and S. Heres and J. Davis},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={2063-2071}
}
  • S. Leucht, M. Tardy, +2 authors J. Davis
  • Published 2012
  • Medicine
  • The Lancet
  • BACKGROUND Relapse prevention with antipsychotic drugs compared with placebo in patients with schizophrenia has not been sufficiently addressed by previous systematic reviews. [...] Key MethodWe searched the Cochrane Schizophrenia Group's specialised register for reports published before Nov 11, 2008; and PubMed, Embase, and ClinicalTrials.gov for those before June 8, 2011. We also contacted pharmaceutical companies and searched the reference lists of included studies and previous reviews.Expand Abstract
    Benefits and harms of antipsychotic drugs in drug-naı̈ve patients with psychosis: A systematic review
    • P. B. Danborga, P. C. Gøtzscheb
    • 2019

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 52 REFERENCES